BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10619024)

  • 1. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways.
    Phillips AC; Ernst MK; Bates S; Rice NR; Vousden KH
    Mol Cell; 1999 Nov; 4(5):771-81. PubMed ID: 10619024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
    Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
    Wang S; Nath N; Minden A; Chellappan S
    EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
    Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the retinoblastoma-dependent Mdm2 and E2F-1 signaling pathways during neuronal apoptosis.
    Trinh E; Boutillier AL; Loeffler JP
    Mol Cell Neurosci; 2001 Feb; 17(2):342-53. PubMed ID: 11178871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA; Rhodes N; Paules RS; Mudryj M
    Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes.
    Hauck L; Hansmann G; Dietz R; von Harsdorf R
    Circ Res; 2002 Nov; 91(9):782-9. PubMed ID: 12411392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
    Koziczak M; Müller H; Helin K; Nagamine Y
    Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
    Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
    Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.
    Yang HL; Dong YB; Elliott MJ; Liu TJ; Atienza C; Stilwell A; McMasters KM
    Clin Cancer Res; 1999 Aug; 5(8):2242-50. PubMed ID: 10473112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of E2F transcription factors by p53 tumor suppressor protein.
    Vaishnav YN; Pant V
    DNA Cell Biol; 1999 Dec; 18(12):911-22. PubMed ID: 10619603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin.
    Meng RD; Phillips P; El-Deiry WS
    Int J Oncol; 1999 Jan; 14(1):5-14. PubMed ID: 9863003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo.
    Agah R; Kirshenbaum LA; Abdellatif M; Truong LD; Chakraborty S; Michael LH; Schneider MD
    J Clin Invest; 1997 Dec; 100(11):2722-8. PubMed ID: 9389735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.
    Rogoff HA; Pickering MT; Frame FM; Debatis ME; Sanchez Y; Jones S; Kowalik TF
    Mol Cell Biol; 2004 Apr; 24(7):2968-77. PubMed ID: 15024084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.